Eton Pharmaceuticals(ETON) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results DEER PARK, Ill., November 6, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton" or "the Company") (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended September 30, 2025. "The third quarter was another stellar period for Eton with product sales growing 129% year over year. The impressive results c ...